Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q3QS
|
||||
Former ID |
DIB013800
|
||||
Drug Name |
4-aminosalicylate sodium (oral controlled release, ulcerative colitis), AGI Therapeutics
|
||||
Synonyms |
AGI-022; Salicylate prodrug (oralcontrolled release, ulcerative colitis), AGI Therapeutics; 4-ASA-Na; 4-ASA-Na (oral, controlled release), AGI Therapeutics
|
||||
Indication | Inflammatory bowel disease [ICD9: 555, 556; ICD10:K50, K51] | Phase 1 | [548169] | ||
Company |
Athpharma Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c(cc(cc1)N)O)C(=O)[O-].[Na+]
|
||||
Target and Pathway | |||||
Target(s) | Cyclooxygenase | Target Info | Modulator | [531873] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.